SARS-CoV-2 virus
COVID-19 genetic risk variant protects against HIV, says study
The study was published in 'Proceedings of the National Academy of Sciences' (PNAS)
Drug that may treat serious COVID-19 complication in children identified
The drug larazotide acetate was administered to four extremely ill children ages 3 to 17
SARS-CoV-2 can damage heart blood vessels without infecting them: Study
The research indicates blocking antibodies could represent a new treatment to alleviate cardiovascular complications
New antibody helps block Covid transmission in cells: Study
The antibody, FuG1, targets the enzyme furin, which the virus uses for its efficient chain of infections in human cells
New low-cost coating for fabrics can kill Covid virus: Study
The coating may be used in future to develop an antiviral spray for fabrics
Vaccine protection better maintained against severe COVID-19: Lancet study
Researchers noted that the protection wanes at different speeds depending on the type of vaccine used
Rosemary compound may block COVID-19 infection, early study suggests
The research found that the compound can block the interaction between the SARS-CoV-2 spike protein and the receptor protein ACE2
Covid may remain active, transmissible for longer than recommended quarantine period
The researchers wanted to know if a period of 14 days was really long enough for the virus to stop being detectable
Nano bubbles could treat, prevent current and future strains of SARS-CoV-2: Study
The study is the first to show evACE2 proteins are capable of fighting the new SARS-CoV-2 variants
Likely order of Covid symptoms depends on coronavirus variant: Study
The study used modelling approach to predict symptom order in a set of 373,883 cases in the US